Free Trial

Twinbeech Capital LP Increases Stake in Crane (NYSE:CR)

Crane logo with Industrials background

Twinbeech Capital LP raised its stake in shares of Crane (NYSE:CR - Free Report) by 65.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 46,422 shares of the conglomerate's stock after acquiring an additional 18,395 shares during the period. Twinbeech Capital LP owned approximately 0.08% of Crane worth $7,045,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of CR. Park Avenue Securities LLC lifted its stake in Crane by 15.0% during the 4th quarter. Park Avenue Securities LLC now owns 3,158 shares of the conglomerate's stock valued at $479,000 after acquiring an additional 412 shares during the period. Diversify Advisory Services LLC lifted its stake in Crane by 23.0% during the 4th quarter. Diversify Advisory Services LLC now owns 2,429 shares of the conglomerate's stock valued at $365,000 after acquiring an additional 454 shares during the period. UMB Bank n.a. lifted its stake in Crane by 69.1% during the 4th quarter. UMB Bank n.a. now owns 372 shares of the conglomerate's stock valued at $56,000 after acquiring an additional 152 shares during the period. Pacer Advisors Inc. lifted its stake in Crane by 37.6% during the 4th quarter. Pacer Advisors Inc. now owns 9,815 shares of the conglomerate's stock valued at $1,489,000 after acquiring an additional 2,681 shares during the period. Finally, Lebenthal Global Advisors LLC bought a new position in shares of Crane in the 4th quarter worth approximately $330,000. Institutional investors own 75.14% of the company's stock.

Crane Stock Up 0.2%

NYSE:CR opened at $178.23 on Tuesday. Crane has a twelve month low of $127.04 and a twelve month high of $188.52. The company has a market cap of $10.25 billion, a price-to-earnings ratio of 23.61, a price-to-earnings-growth ratio of 1.93 and a beta of 1.28. The stock has a fifty day simple moving average of $154.04 and a 200-day simple moving average of $161.47. The company has a current ratio of 1.18, a quick ratio of 0.88 and a debt-to-equity ratio of 0.29.

Crane (NYSE:CR - Get Free Report) last released its earnings results on Monday, April 28th. The conglomerate reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.29 by $0.10. Crane had a return on equity of 24.45% and a net margin of 13.10%. The business had revenue of $557.60 million during the quarter, compared to the consensus estimate of $546.93 million. During the same period last year, the company earned $1.22 earnings per share. The business's revenue for the quarter was up 9.3% compared to the same quarter last year. Analysts anticipate that Crane will post 7.87 EPS for the current year.

Crane Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 11th. Investors of record on Friday, May 30th will be issued a $0.23 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.92 annualized dividend and a dividend yield of 0.52%. Crane's payout ratio is currently 15.94%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft set a $186.00 price target on Crane and gave the stock a "buy" rating in a research report on Monday, April 14th. StockNews.com downgraded Crane from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Stifel Nicolaus raised their price target on Crane from $144.00 to $150.00 and gave the stock a "hold" rating in a research report on Wednesday, April 30th. UBS Group upgraded Crane from a "neutral" rating to a "buy" rating and raised their price target for the stock from $157.00 to $190.00 in a research report on Tuesday, April 29th. Finally, DA Davidson restated a "buy" rating and issued a $200.00 price target on shares of Crane in a research report on Tuesday, March 11th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $178.20.

Read Our Latest Report on CR

Crane Company Profile

(Free Report)

Crane Company, together with its subsidiaries, manufactures and sells engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally. The company operates in three segments: Aerospace & Electronics, Process Flow Technologies, and Engineered Materials.

See Also

Institutional Ownership by Quarter for Crane (NYSE:CR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Crane Right Now?

Before you consider Crane, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crane wasn't on the list.

While Crane currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines